Raymond James analyst Michael Freeman downgraded Village Farms to Market Perform from Outperform with a price target of $2.50, down from $11. The "unsupportive" capital market environment and limited near-term prospects for U.S. cannabis reform create a lack of near-term catalysts for the shares, the analyst tells investors in a research note. The firm also continues to see Village Farms’ fresh produce and U.S. CBD operations dragging on profitability.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VFF: